NEW YORK (
CHANGE IN RATINGS
upgraded at Jefferies from Hold to Buy. $40 price target. Concerns about the future of flash are overblown.
upgraded at Barclays to Outperform from Neutral on attractive valuation. Analysts are looking forward to the release of the next version of Creative Suite, Credit Suisse said. Price target jumped to $39.50 from $35.
upgraded at Thomas Weisel to Market Weight from Underweight as fundamentals of the nitrogen business have been improving. Prices rising faster than costs, analysts mentioned. Price target surged to $68 from $48.
upgraded at Baird from Neutral to Outperform. $89 price target. Stock looks attractive, following the recent pullback.
upgraded at JP Morgan from Neutral to Overweight. $50 price target. Company should benefit from a weaker Australian dollar.
reinstated with Neutral rating at Goldman. Coverage of C was reinstated with a Neutral rating. $3.50 price target. Restructuring is complete, but near-term earnings power remains weak.
upgraded at UBS from Neutral to Buy. $42 price target. Stock has underperformed it peers, but could be a clear winner in this cycle.
upgraded at BofA/Merrill to Buy from Neutral. High short interest, valuation, and likely EPS revision should drive better share performance in 2010. Price target raised to $18 from $16.50. 2010 and 2011 EPS estimates set at $1.06 and $1.31, respectively.
upgraded at JP Morgan from Neutral to Overweight. $88 price target. Stock offers an attractive value proposition, even without the spin-off of the unregulated nuclear fleet.
downgraded at JP Morgan to Neutral. Stock has outperformed BTU by 140% over the past year. $43 price target.
upgraded at BofA/Merrill to Buy from Neutral on belief that market shares gains are ahead. Price target boosted to $48. 2010 and 2011 EPS estimates set at $2.13 and $2.42, respectively.
downgraded at Thomas Weisel to Market Weight from Overweight on valuation. Maintain $15 price target. 2009 and 2010 EPS estimates set at -$0.18 and -$0.05, respectively.
downgraded at JP Morgan from Overweight to Neutral. $48 price target. Valuation call, as the stock has outperformed its peers by 10% over the past 6 months.
upgraded at Baird from Neutral to Outperform. $34 price target. Company is seeing better sales across the board.
STOCK COMMENTS / EPS CHANGES
estimates upped at Goldman through 2011. Expect the agriculture commodity outlook to improve through 2010. Neutral rating and $40 price target.
estimates, target lowered at Goldman. Shares of ANR now seen reaching $58. Estimates also reduced, because of lower thermal volumes and higher costs. Buy rating.
estimates, target reduced at UBS. BCO estimates were cut through 2010. International margins will be soft. Neutral rating and new $25 price target.
estimates, target boosted at Goldman. Shares of BIDU now seen reaching $575. Estimates also raised, given the company's new guidance. Buy rating.
estimates boosted at UBS through 2010. Company gave better guidance, aided by the tax rate and share buybacks. Neutral rating and $55 price target.
target, estimate boosted at Credit Suisse. CAM price target raised to $48 from $45 on higher subsea revenue and a lower tax rate in 2010. Maintain Neutral rating. 2011 EPS estimate improved to $2.70, 2010 held at $2.35.
Church & Dwight
numbers boosted at Goldman through 2011. Company is seeing balanced sales growth. Neutral rating and new $68 price target.
cut from Conviction Sell List at Goldman. Valuation call, based on a $13 price target.
Charles River Labs
numbers boosted at Morgan Stanley. CRL estimates were increased through 2011. Company seeing higher margins, but have yet to see an increase in underlying demand. Underweight rating and new $40 price target.
estimates boosted at Barclays. DIS 2010 and 2011 EPS estimates increased to $2.00 and $2.30, respectively. Maintain Overweight rating and $36 price target.
estimates, target raised at Goldman. Shares of DIS now seen reaching $33. Estimates also increased, because of strong sales across the board. Neutral rating.
price target boosted at Credit Suisse to $27 from $24 on share buyback. 2010 and 2011 EPS estimates set at 23 cents and 49 cents, respectively. Outperform rating.
estimates boosted at Goldman through 2011. Company is posting strong results and buying back stock. Buy rating and $28 price target.
estimates raised at UBS through 2011. Company is seeing strong sales in China and India. Neutral rating and $62 price target.
target, estimates higher at BofA/Merrill. MCD price target raised by a dollar to $71. 2010 and 2011 EPS estimates improved to $4.44 and $4.90, respectively. Maintain Buy rating.
numbers lowered at UBS Shares of MLM now seen reaching $97. Estimates also cut, as the company's rebound will be delayed. Buy rating.
cut from Conviction Buy List at Goldman. Estimates also lowered, as the company is facing higher variable costs. New $98 price target.
price target cut at Barclays by a dollar to $65 as potash and phosphate prices are revised. Equal Weight rating. 2010 and 2011 EPS estimates trimmed to $2.27 and $4.03, respectively.
estimates, target increased at Morgan Stanley. Shares of NVDA now seen reaching $10.50. Estimates also boosted, given stronger overall PC demand. Underweight rating.
estimates upped at Goldman through 2011. Company is seeing lower compensation expenses and tax rate. Neutral rating and $30 price target.
numbers raised at FBR. Shares of SIVB now seen reaching $42. Estimates also increased, because of higher expected net interest income and lower loss provisions. Market Perform rating.
numbers lowered at UBS. TAP estimates were cut through 2011. Company is seeing less operating leverage in the U.S. Buy rating and new $50 price target.
numbers reduced at Goldman through 2011. Company is facing higher costs and interest expense. Buy rating and new $22 price target.
estimates lowered at UBS. VMC estimates were cut through 2011. Expect a more muted recovery this year. Buy rating and $54 price target.
estimates, target boosted at UBS. XL estimates were raised through 2011. Company is back on the right track and boosted guidance. Buy rating and new $21.50 price target.
This article was written by a staff member of TheStreet.com.